German family-owned drugmaker Grünenthal, a global leader in pain management and research, has published 2025 financial ...

British pharma AstraZeneca (LSE: AZN) said its antibody tozorakimab met the primary endpoint in two Phase III trials, ...

Japan’s Otsuka Pharmaceutical is to buy US firm Transcend Therapeutics for $700 million upfront and up to $525 million in milestones, for a total potential consideration of $1.225 billion.

British pharma major GSK (LSE: GSK) is bringing its hepatitis B vaccine Engerix B (hepatitis B vaccine) back to China through ...

Italian drugmaker Recordati (XMIL: REC) has confirmed it received a non-binding takeover approach from private equity firm ...

Danish pharma major Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Awiqli (insulin icodec ...

Swiss pharma giant Novartis (today announced that it has entered into an agreement to acquire Excellergy, a private biotech ...

Braveheart Bio, a US biotech developing therapeutics for hypertrophic cardiomyopathy (HCM) and related cardiovascular ...